USP7 and cancer: Interest in USP7 has been intensified when it was implicated in modulating the degradation of the tumor suppressor p53 through the stabilization of its major E3 ligase, murine double minute 2 (MDM2), causing dysregulation of the MDM2-p53 pathway in malignant tumors.